Psoriasis Treatment - Yesterday, Today, and Tomorrow

Acta Dermatovenerologica Croatica

Volumn 12, Issue 1, 2004, Pages 30-34

  Gruber, Franjo ^a   Kaštelan, Marija ^a   Brajac, Ines ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

History; Psoriasis; Treatment

Indexed keywords

ACETIC ACID; ANTIINFECTIVE AGENT; ANTIMETABOLITE; ANTRAROBINE; ARSENIC ACID; BETAMETHASONE VALERATE; CHRYSAROBIN; CLOBETASOL PROPIONATE; COAL TAR; CORTICOSTEROID; CORTISONE; CYCLOSPORIN; CYTOSTATIC AGENT; DITHRANOL; ETRETIN; ETRETINATE; FLUOCINOLONE ACETONIDE; HYDROCORTISONE; ICHTHAMMOL; IMMUNOSUPPRESSIVE AGENT; IODINE; MERCURY; METHOTREXATE; PHENOL; PSORALEN; RETINOID; TAR; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

DIET THERAPY; DRUG RECEPTOR BINDING; HISTORY OF MEDICINE; HUMAN; KERATITIS; LIVER TOXICITY; NEPHROTOXICITY; PRURITUS; PSORIASIS; PUVA; REVIEW; SIDE EFFECT; SKIN ATROPHY; SKIN IRRITATION; TACHYPHYLAXIS; ULTRAVIOLET RADIATION;

FORECASTING; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; PSORIASIS;

EID: 1942436171     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Ebbel B. The papirus Ebers. Copenhagen 1937.
2. Goldman L, Moraites RS, Kitzmiller K. White spots in Biblical times. Arch Dermatol 1966;93:748-53.
3. Hippocrate. Ouvres completes. Littre E, transl. and editor. Paris: Bailliere et fils; 1839-1861.
4. Celsus CA. De medicina, Spencer WG, transl. Book V, 17. Cambridge: Harvard University Press; 1989. p. 168-73.
5. Plinius C. Naturalis historia. Cambridge: Harvard University Press; 1969. p. XXIII.3.
6. Galenus C. Opera omnia. Kuhn C, editor. Lipsia: Cnobloch; 1830. p. 449.
7. Holubar K. Psoriasis 100 years ago. Dermatologica 1990;180:1-4.
8. Shafii M, Shafii SL. Exploratory psychotherapy in the treatment of psoriasis twelve hundred years ago. Arch Gen Psychiatry 1979;36:1242-5.
9. Carl Linnaeus. Genera morborum. Uppsala; 1763.
10. Plenck JJ. Doctrina de morbis cutaneis, Wien; 1776.
11. Willan R. On cutaneous diseases. London: Johnson St. Paul's Church Yard; 1809.
12. Alibert JL. Monographie des dermatoses. Precis theorique et pratique des maladies de la peau. Paris: Daynac; 1832.
13. Hebra F. Atlas der Hautkrankheiten. Vol I-X, Wien; 1856-1876.
14. Girdlestone T. Observation on the effect of dr Fowler's mineral solution in leprosy and other diseases. Med Phys J 1806;15:297.
15. Fowler T. Medical reports of the effects of arsenic in the cure of agues, remitting fevers and periodical headaches. London Med J 1786;7:192-205.
16. rd ed. London: Bonurike; 1726. p. 45.
17. Brault J. Deux cas de psoriasis traite par les injections mercurielles. Bull Soc Franc Dermatol 1895:332.
18. Jadassohn W, Kogoj F. Bemerkungen zur psoriasis-therapie. Zbornik radova sa VII kongresa dermatovenerologa Jugoslavije. Opatija-Rijeka, Yugoslavia, 1972; p. 65.
19. Squire B. On the treatment of psoriasis by an ointment of chrysophanic acid. London: Churchill; 1878. p. 8.
20. Swanbeck G. Der Baum, aus welchem Chrysarobin gewonnen wurde. Haut-arzt 1992;43:388-9.
21. Galewsky E. Über Cignolin, ein Ersatzpräparat des Chrysarobins. Derm Wschr 1916;62:113-5.
22. Leigheb V. II valore pratico attuale della terapia esterna medicamentosa delle malattie cutanee. Minerva Dermatol 1958;33 Suppl 1:81-2.
23. Goeckerman WH. Treatment of psoriasis. Northwest Med 1925;24:229.
24. Alderson HE. Heliotherapy for psoriasis. Arch Dermatol 1923;8:79-80.
25. Tronnier H, Schule N. Zur dermatologischen Therapie von Dermatosen mit Langwelligen UV nach Photosensibilisirung der Haut mit Methoxsalen, erste Ergebnisse bei Psoriasis vulgaris. Zeitschr Haut Geschlkr 1973;48:385-93.
26. Parrish JA, Fitzpatrick TB, Tannenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxalen and long wave ultraviolet light. N Engl J Med 1974;291:1207-11.
27. Edmundson WF, Guy BW. Treatment of psoriasis with folic acid antagonists. Arch Dermatol 1958;78:200-3.
28. Nobl G. Psoriasis. In: Jadassohn J. Handbuch der Haut und Geschlechts-krankheiten. Vol. VII. Berlin: Springer; 1928. p. 180-288.
29. Nardelli L. La psoriasi nella storia della medicina. G Ital Dermat 1959;100:363-88.
30. Mueller W, Herrmann B. Ciclosporin A for psoriasis. N Engl J Med 1979;30:555.
31. Kingston T, Matt L, Lowe N. Etretin therapy for severe psoriasis. Arch Dermatol 1987;123:55-8.
32. Nickoloff BJ, Wrone-Smith I. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999;155:145-58.
33. Kirby B, Griffiths CE. Psoriasis: the future. Br J Dermatol 2001;144 Suppl 58:37-43.
34. Tutrone WD, Saini R, Weinberg JM. Biological therapy for psoriasis: An overview of infliximab, etanercept, efalizumab and alefacept. Drugs 2004;7:45-9.
35. Mrowietz U. Therapie der Psoriasis mit Biologicals. Hautarzt 2003;54:224-9.
36. Sobell JM, Hallas SJ. Systemic therapies for psoriasis: understanding current and newly emerging therapies. Sem Cutan Med Surg 2003;22:187-95.
37. Boehncke WH. Immunomodulatory drugs for psoriasis. New "biologics" offer promise. BMJ 2003;327:634-5.
38. Bowcock AM, Barker JN. Genetics of psoriasis: the potential impact on new therapies. J Am Acad Dermatol 2003;49 Suppl 2:51-6.